Octreotide acetate injection is a synthetic form of the hormone somatostatin, used to treat conditions like acromegaly, carcinoid syndrome, and certain pituitary tumors [1]. It works by inhibiting the release of hormones such as growth hormone, insulin, and glucagon [1][2].
How does octreotide acetate injection work for carcinoid syndrome?
For carcinoid syndrome, octreotide acetate injection helps control symptoms like flushing and diarrhea by reducing the excessive hormones, such as serotonin and tachykinins, released by the carcinoid tumors [1].
What are the approved uses of octreotide acetate injection?
Octreotide acetate injection is approved for managing symptoms of carcinoid tumors, treating acromegaly, and for treatment of specific pituitary tumors called thyrotropin-secreting adenomas [1]. It is also used to reduce the frequency of pancreatic, intestinal, and bile duct infections in patients with acquired immunodeficiency syndrome (AIDS) who have undergone abdominal surgery [1].
When does the patent for octreotide acetate expire?
The patent landscape for octreotide acetate is complex, with original patents having expired. However, there can be multiple patents covering different aspects of the drug, including formulations and methods of use. For detailed information on specific patent expirations and ongoing patent challenges, DrugPatentWatch.com provides a resource [3].
Can biosimilars of octreotide acetate injection be developed?
Yes, biosimilars can be developed for biologic drugs like octreotide acetate injection once the relevant patents and exclusivity periods expire. The development and approval process for biosimilars is rigorous, requiring demonstration of high similarity to the reference product [4].
What are the potential side effects of octreotide acetate injection?
Common side effects include gastrointestinal issues such as diarrhea, abdominal pain, nausea, and gas. Other potential side effects involve gallstones, fatigue, headache, and hyperglycemia or hypoglycemia [1].
How is octreotide acetate injection administered?
Octreotide acetate injection is typically administered subcutaneously (under the skin) or intravenously (into a vein) [1]. Extended-release formulations are also available for intramuscular injection, which are given by a healthcare professional [1].
What is the difference between octreotide and somatostatin?
Octreotide is a synthetic analog of the natural hormone somatostatin. While they share similar functions, octreotide is designed to be more potent and have a longer duration of action compared to naturally occurring somatostatin [1][2].
How does octreotide acetate compare to lanreotide?
Both octreotide acetate and lanreotide are somatostatin analogs used to treat similar conditions like acromegaly and carcinoid syndrome. They work by suppressing the release of various hormones. Differences may lie in their specific pharmacokinetic profiles, dosing frequencies, and sometimes in their efficacy or side effect profiles for certain patient populations [5].
What is the cost or pricing of octreotide acetate injection?
The cost of octreotide acetate injection can vary significantly based on the dosage, formulation (e.g., short-acting vs. long-acting), quantity, and insurance coverage. Generic versions may be available, potentially impacting pricing. Specific pricing information would typically be obtained from pharmacies or healthcare providers [6].